Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,659,199
  • Shares Outstanding, K 111,030
  • Annual Sales, $ 408,830 K
  • Annual Income, $ 8,010 K
  • 60-Month Beta 0.73
  • Price/Sales 12.71
  • Price/Cash Flow 115.32
  • Price/Book 8.13
Trade NEO with:

Options Overview

Details
  • Implied Volatility 55.86%
  • Historical Volatility 41.10%
  • IV Percentile 59%
  • IV Rank 15.67%
  • IV High 163.52% on 03/16/20
  • IV Low 35.86% on 07/06/20
  • Put/Call Vol Ratio 4.30
  • Today's Volume 832
  • Volume Avg (30-Day) 630
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 5,049
  • Open Int (30-Day) 5,881

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.03
  • Number of Estimates 2
  • High Estimate 0.05
  • Low Estimate 0.01
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +175.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.27 +3.45%
on 02/26/21
61.57 -17.22%
on 02/16/21
-3.95 (-7.19%)
since 01/26/21
3-Month
45.86 +11.13%
on 11/27/20
61.57 -17.22%
on 02/16/21
+5.26 (+11.51%)
since 11/25/20
52-Week
20.47 +149.00%
on 03/12/20
61.57 -17.22%
on 02/16/21
+20.98 (+69.96%)
since 02/26/20

Most Recent Stories

More News
NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference

FT. MYERS, FL / ACCESSWIRE / February 25, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...

NEO : 50.97 (+0.22%)
NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter

NEO : 50.97 (+0.22%)
NeoGenomics Announces CEO Succession

Mark Mallon named CEO effective April 2021; Douglas M. VanOort will retire as CEO and transition to executive chairman of the board of directors

IRWD : 9.23 (+2.10%)
NEO : 50.97 (+0.22%)
NeoGenomics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 24, 2021 / NeoGenomics, Inc. (NASDAQ:NEO) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 24, 2021 at 8:30...

NEO : 50.97 (+0.22%)
NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference

FT. MYERS, FL / ACCESSWIRE / February 16, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...

NEO : 50.97 (+0.22%)
NASDAQ Closes Above 14K on Fourth Day of Record Highs

NASDAQ Closes Above 14K on Fourth Day of Record Highs

FLL : 7.14 (-2.46%)
SON : 59.57 (-2.02%)
VIVO : 21.08 (-2.90%)
PENN : 115.78 (+5.55%)
OSTK : 67.17 (-4.23%)
SQQQ : 14.48 (-1.50%)
NEO : 50.97 (+0.22%)
APHA : 17.84 (-2.09%)
AYX : 95.60 (-1.26%)
TAL : 77.54 (-0.17%)
GDRX : 44.52 (-2.26%)
ARTL : 1.8400 (-5.64%)
ARMK : 37.12 (-2.03%)
INTU : 390.14 (+0.56%)
MAR : 148.07 (-1.35%)
CGC : 32.75 (-1.39%)
KO : 48.99 (-2.35%)
UBER : 51.75 (+0.58%)
GM : 51.33 (+1.44%)
CME : 199.70 (-2.49%)
NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021

FT. MYERS, FL / ACCESSWIRE / February 5, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans...

NEO : 50.97 (+0.22%)
Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials

Access to industry-leading genomic database and real-world evidence designed to optimize trial design, site selection, clinical trial matching and translational research

NEO : 50.97 (+0.22%)
NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition

, /PRNewswire/ -- The Access to Comprehensive Genomic Profiling Coalition (ACGP) announced today the addition of NeoGenomics, Inc. (NASDAQ: NEO) and Tempus to its coalition of diagnostics companies and...

NEO : 50.97 (+0.22%)
NASDAQ Winning Streak Ends as Stocks Slip Slightly

NASDAQ Winning Streak Ends as Stocks Slip Slightly

FNKO : 13.58 (+3.19%)
VET : 6.29 (-3.38%)
DNOW : 10.63 (-3.01%)
HIMX : 13.47 (+2.36%)
SAVA : 48.58 (-4.52%)
ETSY : 220.27 (+11.48%)
VCEL : 48.28 (+1.49%)
KMT : 37.36 (-2.43%)
STMP : 181.93 (-1.29%)
OSTK : 67.17 (-4.23%)
NTAP : 62.60 (+2.27%)
NEO : 50.97 (+0.22%)
VZ : 55.30 (-2.12%)
IIPR : 195.00 (+3.37%)
CRON : 10.45 (-3.15%)
HEXO : 6.99 (-2.37%)
APHA : 17.84 (-2.09%)
MSFT : 232.38 (+1.48%)
MMM : 175.06 (-2.07%)
JNJ : 158.46 (-2.64%)
GME : 101.74 (-6.43%)
AAPL : 121.26 (+0.22%)
FB : 257.62 (+1.15%)
TSLA : 675.50 (-0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 54.48
2nd Resistance Point 53.10
1st Resistance Point 52.03
Last Price 50.97
1st Support Level 49.59
2nd Support Level 48.21
3rd Support Level 47.14

See More

52-Week High 61.57
Last Price 50.97
Fibonacci 61.8% 45.87
Fibonacci 50% 41.02
Fibonacci 38.2% 36.17
52-Week Low 20.47

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar